For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220715:nRSO7027Sa&default-theme=true
RNS Number : 7027S F&C Investment Trust PLC 15 July 2022
F&C INVESTMENT TRUST PLC
LEI: 213800W6B18ZHTNG7371
All data as at 30 June 2022
This data will shortly be available on the Company's website www.fandcit.com
(http://www.fandcit.com)
%
Twenty Largest Listed Equity Holdings
Microsoft 2.2
Alphabet 2.0
UnitedHealth 1.9
Apple 1.8
Amazon 1.3
Elevance Health 1.0
Dollar General 1.0
Merck & Co 0.9
Taiwan Semiconductor Manufacturing Company 0.8
CVS Health 0.8
International Flavors & Fragrances 0.8
Broadcom 0.8
AstraZeneca 0.8
VICI Properties 0.7
Hess 0.7
Wells Fargo 0.7
Philips 66 0.7
Tesla 0.7
GSK 0.7
Mastercard 0.7
Total 21.0
Asset Allocation %
UK Equity 10.6
Europe ex UK Equity 11.6
North America Equity 53.3
Japan Equity 6.4
Developed Pacific Equity 3.5
Emerging Markets Equity 7.8
Liquidity 6.7
Total 100.0
Note: All percentages are based on Gross Assets. Figures are subject to
rounding.
Net Gearing 4%
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END PFUBSGDRLUBDGDU